- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01518660
Multiple Sclerosis and Progressive Resistance Training
Multiple Sclerosis - Inflammatory, Neurological and Muscular Adaptations to Progressive Resistance Training
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Exercise in general, and progressive resistance training (PRT) in particular, is regarded as an important tool in the rehabilitation of people with multiple sclerosis (MS).
Previous studies have reported positive effects of PRT on muscle strength, functional capacity, fatigue and quality of life. Also, a possible disease modifying effect has been proposed. However, the underlying physiological mechanisms that might explain these beneficial effects and the possible effects on disease progression are unresolved. Additionally, none of the previous studies has been concerned with the possible impact of MS progression type, gender and/or medication.
The purpose of this randomized, controlled, gender stratified trial is to investigate underlying mechanisms possibly explaining the beneficial effects of progressive resistance training for people with multiple sclerosis.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Aarhus C, Danmark, 8000
- MS Clinic, Department of Neurology, Aarhus University Hospital
-
Aarhus C, Danmark, 8000
- Sport Science, Aarhus University
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Diagnosed relapsing-remitting MS according to the McDonald criteria
- Expanded Disability Status Scale (EDSS) between 2.0 and 5.5
- Be able to train twice a week at the University
- Use interferon based medication
Exclusion Criteria:
- Alcohol abuse, Alzheimer's and pacemaker (or other metallic implant)
- Comorbidities like cardiovascular-, respiratory-, orthopaedic or metabolic diseases
- Having had an attack in a period of 8 weeks prior to the start of the intervention period
- Having an attack during the intervention period
- Pregnancy
- Systematic resistance training in a period of 3 months prior to the start of the intervention period.
- Training adherence of less than 85%.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Inget ingripande: Kontrollera
|
|
Experimentell: Träning
|
Bi-weekly progressive resistance training
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Blood-borne biomarkers
Tidsram: Change from baseline to 24 weeks
|
Resting levels of bloodbourne biomarkers;
|
Change from baseline to 24 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Neuro-muscular function of knee extensors
Tidsram: Change from baseline to 24 weeks
|
By use of an isokinetic dynamometer, EMG and stimulation equipment the following will be assessed for the knee extensors;
|
Change from baseline to 24 weeks
|
Walking performance
Tidsram: Change from baseline to 24 weeks
|
Walking performance will be assessed by the;
|
Change from baseline to 24 weeks
|
Self-reported measures
Tidsram: Change from baseline to 24 weeks
|
The self-reported measures contains questionnaires regarding;
|
Change from baseline to 24 weeks
|
Brain volume
Tidsram: Change from baseline to 24 weeks
|
MRI-scans of the head will provide the following measurements;
|
Change from baseline to 24 weeks
|
Body Composition
Tidsram: Change from baseline to 24 weeks
|
Weight and Bodyfat-% will be assessed with a Bodycomposition weight (Tanita SC220)
|
Change from baseline to 24 weeks
|
Thigh muscle cross-sectional area
Tidsram: Change from baseline to 24 weeks
|
MRI-scans of the thigh will provide cross-sectional area of
|
Change from baseline to 24 weeks
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Tue Kjølhede, M.Sc., Sport Science, Department of Public Health, Aarhus University
- Studiestol: Ulrik Dalgas, Ph.D., Sport Science, Department of Public Health, Aarhus University
- Studiestol: Kristian Vissing, Ph.D., Sport Science, Department of Public Health, Aarhus University
- Studiestol: Thor Petersen, Dr.med, MS Clinic, Department of Neurology, Aarhus University Hospital
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- MS&PRT_SSAU_TK
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Multiple Sclerosis (Relapsing Remitting)
-
Asuman KucukonerAvslutadMultipel skleros-Relapsing-RemittingKalkon
-
McGill UniversityNovartisAvslutadMultipel skleros-Relapsing-RemittingKanada
-
University Hospital MuensterOkändKliniskt isolerat syndrom, CNS demyeliniserande | Multipel skleros - Relapsing RemittingTyskland
-
Association de Recherche Bibliographique pour les...Centre Hospitalier Universitaire de Nice; Centre Hospitalier Princesse...AvslutadFriska | Kliniskt isolerat syndrom | Multipel skleros (MS) | Radiologiskt isolerat syndrom | Multipel skleros (MS) Relapsing Remitting | Multipel skleros (MS) Primär progressiv | Multipel skleros (MS) Sekundär progressivMonaco
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development... och andra samarbetspartnersRekryteringMultipel skleros | Multipel skleros, sekundär progressiv | Multipel skleros-Relapsing-RemittingFörenta staterna
-
RenJi HospitalAbelZeta Pharma Inc.RekryteringSystemisk lupus erythematosus (SLE) | Neuromyelit Optica Spectrum Disorders | Immunförmedlad nekrotiserande myopati | Multipel skleros-Relapsing-RemittingKina
Kliniska prövningar på Training
-
University of California, San FranciscoAvslutad
-
Madonna Rehabilitation HospitalAktiv, inte rekryterandeNeurologisk skada | Neurologiska sjukdomar eller tillståndFörenta staterna
-
Yale UniversityAvslutadPsykisk hälsoproblem (t.ex. depression, psykos, personlighetsstörning, missbruk) | Psykisk hälsa 1 | Krigsrelaterat traumaJordanien
-
University of HawaiiNational Institute on Drug Abuse (NIDA); University of Maryland, BaltimoreOkänd
-
Florida State UniversityRekrytering
-
Florida State UniversityNational Institute of Mental Health (NIMH); National Institutes of Health...Avslutad
-
University of MagdeburgAvslutadHjärnskador, traumatiska | HemianopiTyskland
-
University of KentuckyNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) och andra samarbetspartnersRekryteringDiabetes mellitus, typ 2Förenta staterna
-
Florida State UniversityRekrytering